Year: 2003 Source: The Canadian Child and Adolescent Psychiatry Review, v.12, no.4, (November 2003), p.101-102 SIEC No: 20070598

This letter focuses on the impact of the announcement of results from clinical trial data on the safety & efficacy of paroxetine & venlafaxine in pediatric populations, specifically the effect on clinical practice. A number of trials are briefly reviewed & the letter concludes with a list of suggested policies & procedures when using psychotropic medications with pediatric patients. (10 refs.)